Skip to content

Vivani Medical VANI Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

Amgen logo
AmgenAMGN
Prime Medicine logo
Prime MedicinePRME

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's unrealized gains on investments?
Vivani Medical (VANI) reported unrealized gains on investments of $1.92M in Q4 2025.
What is the long-term trend for Vivani Medical's unrealized gains on investments?
Over 3 years (2022 to 2025), Vivani Medical's unrealized gains on investments has grown at a 8.4% compound annual growth rate (CAGR), from $1.51M to $1.92M.
What does unrealized gains on investments mean?
This represents the cumulative increase in the fair value of investment securities held by the company that have not yet been sold. It reflects the market-based performance of the company's treasury or investment portfolio and is typically recorded within accumulated other comprehensive income.